Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy Study of NH001 in Vegetative State & Minimally Conscious State Following a Traumatic Brain Injury (NH001-2)

This study has suspended participant recruitment.
FDA Office of Orphan Products Development
Information provided by (Responsible Party):
NeuroHealing Pharmaceuticals Inc. Identifier:
First received: September 26, 2008
Last updated: August 6, 2015
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)